Ghent University Academic Bibliography

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

E. G. Garcia, A. Veloso, M. L. Oliveira, J. R. Allen, S. Loontiens, D. Brunson, D. Do, C. Yan, R. Morris, S. Iyer, et al.

(2021) LEUKEMIA. 35. p.679-690

Add to list

Journal Article
A1
open access

HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development

Matthias De Decker (UGent) , Marieke Lavaert (UGent) , Juliette Roels (UGent) , Laurentijn Tilleman (UGent) , Bart Vandekerckhove (UGent) , Georges Leclercq (UGent) , Filip Van Nieuwerburgh (UGent) , Pieter Van Vlierberghe (UGent) and Tom Taghon (UGent)

(2021) HAEMATOLOGICA. 106(1). p.130-141

Add to list

Miscellaneous
open access

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation : a brief commentary

Elise Wouters, Maurice Steenhuis, Hubert Schrezenmeier, Pierre Tiberghien, Heli Harvala, Hendrik Feys (UGent) and Ellen Schoot

(2021) VOX SANGUINIS.

Add to list

Using the World Apheresis Association registry helps to improve the treatment quality of therapeutic apheresis

Bernd Stegmayr, Elizabeth Newman, Volker Witt, Kurt Derfler, Gerda Leitner, Sunny Eloot (UGent) , Annemieke Dhondt (UGent) , Dries Deeren, Jan Ptak, Milan Blaha, et al.

(2021) TRANSFUSION MEDICINE AND HEMOTHERAPY. 48(4). p.234-239

Add to list

T-ALL can evolve to oncogene independence

Hesham Abdulla, Anh Vo, Benjamin J. Shields, Tenae J. Davies, Jacob T. Jackson, Raed Alserihi, Elizabeth M. Viney, Tin Wong, Feng Yan, Nicholas C. Wong, et al.

(2021) LEUKEMIA. 35(8). p.2205-2219

Add to list

Journal Article
A1
open access

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Melanie Decker, Tim Lammens (UGent) , Alina Ferster, Miriam Erlacher, Ayami Yoshimi, Charlotte M. Niemeyer, Martijn P. T. Ernst, Marc H. G. P. Raaijmakers, Nicolas Duployez, Andreas Flaum, et al.

(2021) LEUKEMIA. 35(11). p.3304-3308

Add to list

Journal Article
A1
open access

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Judith M. Boer, Maria Grazia Valsecchi, Femke M. Hormann, Željko Antić, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloé Arfeuille, Hélène Cavé, Andishe Attarbaschi, et al.

(2021) LEUKEMIA. 35(10). p.2978-2982

Add to list

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Thierry Facon, Christopher P. Venner, Nizar J. Bahlis, Fritz Offner (UGent) , Darrell J. White, Lionel Karlin, Lotfi Benboubker, Sophie Rigaudeau, Philippe Rodon, Eric Voog, et al.

(2021) BLOOD. 137(26). p.3616-3628

Add to list

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study

Cyrille Hulin, Fritz Offner (UGent) , Philippe Moreau, Murielle Roussel, Karim Belhadj, Lotfi Benboubker, Denis Caillot, Thierry Facon, Laurent Garderet, Frederique Kuhnowski, et al.

(2021) HAEMATOLOGICA. 106(8). p.2257-2260

Add to list

Journal Article
A1
open access

Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

Jochen Buechner, Stephan A. Grupp, Hidefumi Hiramatsu, David T. Teachey, Susana Rives, Theodore W. Laetsch, Gregory A. Yanik, Patricia Wood, Rakesh Awasthi, Lan Yi, et al.

(2021) BLOOD ADVANCES. 5(2). p.593-601

Academic Bibliography

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation : a brief commentary

Using the World Apheresis Association registry helps to improve the treatment quality of therapeutic apheresis

T-ALL can evolve to oncogene independence

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study

Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

Contents

Support

Contact